Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation. More than 10,000 people with self-reported and diagnosed type 2 diabetes and more than 6,500 treating-physicians from 26 countries to take part in new survey (Boehringer Ingelheim)
Diabetes News
Category: Audits
National Diabetes Audit – 2011-12: Report 2
This national report from the ninth year of the NDA, presents key findings on complications in 2010-2012 and deaths in 2012 for all age groups (Health and Social Care Information Centre)
Unlocking funding for childhood diabetes in the UK
The introduction of the BPT is encouraging more paediatric diabetes specialists to consider the valuable role technology can play in enhancing service delivery. For those that have already embraced it, the results are better for the NHS, better for healthcare professionals and, most important of all, better for patients (British Journal of Diabetes & Vascular Disease)
IDF Diabetes Atlas
The 6th Edition of the IDF Diabetes Atlas generates estimates using new studies that became available in the last year, and updated population estimates. The new estimates follow the same upward trajectory evidenced by previous editions of the Atlas, and add urgency to the need for effective prevention, treatment, and an end to silence and discrimination (IDF)
Lifetime Direct Medical Costs of Treating T2D & Complications
Over the lifetime, type 2 diabetes imposes a substantial economic burden on healthcare systems. Effective interventions that prevent or delay type 2 diabetes and diabetic complications might result in substantial long-term savings in healthcare costs (American Journal of Preventive Medicine)
Costs of hypoglycemia with T2D and insulin glargine
Patients with T2DM initiating insulin glargine treatment showed low rates of hypoglycemia, especially when using a disposable pen device. Hypoglycemia-related costs were low, contributing a very small proportion to overall diabetes-related healthcare costs (Journal of Medical Economics)
Evaluation of insulin initiation on resource utilization & costs
Contributors to total cost differed between countries, potentially reflecting local clinical practice patterns and insulin regimens. In each country, mean direct total costs of T2DM care increased during the first 6 months after insulin initiation and decreased thereafter (Journal of Medical Economics)
The management of adult diabetes services in the NHS
Seventeenth Report of Session 2012–13. together with formal minutes, oral and written evidence (House of Commons, UK)
The 2010-2011 National Diabetes Audit
Report on care processes and treatment targets in England and Wales (NHS)
- « Previous Page
- 1
- …
- 4
- 5
- 6